Case report
Imported rickettsioses in Italy

https://doi.org/10.1016/j.tmaid.2012.05.003Get rights and content

Summary

Background

In Italy few cases of rickettsioses have been reported in travellers and autochthonous cases are attributed predominantly to Rickettsia conorii, the agent of Mediterranean spotted fever.

Method

The purpose of this study was to investigate some epidemiological and clinical features of tick-borne spotted fever group rickettsiosis acquired abroad or in Italy. Serum specimens collected prospectively from patients with suspected rickettsioses were tested by immunofluorescence assay. A definitive diagnosis was made on the basis of positive serological test results at the WHO collaborative centre for rickettsial diseases, Marseille, France. We compared the clinical features of patients with confirmed rickettsioses and those showing typical clinical symptoms/signs without definitive diagnose.

Results

Eight of 26 patients suspected cases had confirmed rickettsioses. All patients were travellers returning from southern Africa (75% Rickettsia africae). Inoculation eschars were significantly more common in patients with confirmed rickettsioses (p = 0.004).

Conclusions

Our study demonstrates that R. africae is the most frequent rickettsia observed in Italian travellers. Prior to receiving the laboratory results, physicians should start empirical treatment on the basis of epidemiologic data (e.g., travel history to Africa), and clinical findings compatible with rickettsioses (e.g., eschars).

Introduction

New rickettsial species have been identified over the past few years as a consequence of the use of cell culture systems and sequence-based molecular identification technique.1, 2 Recent studies suggest that 2% of fever in ill travellers returned from the developing world is caused by rickettsioses.3, 4 Rickettsioses observed most frequently are African tick bite fever (ATBF) and Mediterranean spotted fever (MSF).2, 5

Few cases of tick-borne spotted fever group (SFG) rickettsioses have been reported in travellers returning to Italy from endemic areas, probably due to non-specific clinical signs and limited availability of diagnostic tests.6, 7 The diagnosis of tick-borne SFG rickettsioses in Italy is confirmed by non-specific serologic assay (indirect immunofluorescence reaction, ELISA, Weil Felix) with issues of cross-reactivity. It is therefore likely that within the autochthonous MSF cases reported each year some are caused by other species.8

The purpose of this Italian Rickettsioses Surveillance Study (IRiSS) was to investigate some epidemiological and clinical features of tick-borne SFG rickettsioses acquired abroad or in Italy.

Section snippets

Materials and methods

The cases were collected prospectively within the Gruppo di Interesse e Studio delle Patologie di Importazione (GISPI), a network of Institutes for Infectious and Tropical Diseases in Northern Italy. Diagnosis of tick-borne SFG rickettsioses was suspected when three or more symptoms and/or signs were presents: fever (T ≥ 38 °C), rash, eschar, headache, alopecia, lymphangitis, and satellite lymphadenopathy.

Two categories were defined: imported rickettsioses, when the symptoms and/or signs were

Results

From September 2005 to September 2009 a total of 26 suspected cases of tick-borne SFG rickettsioses were observed (20 imported and 6 autochthonous).

Eight tick-borne SFG rickettsioses (30.8%) were confirmed by serology. Only one patient (1/4, 25.0%) had acute-phase serum sample positive whereas eight patients (8/8, 100%) had convalescent-phase serum samples positive (Table 1). After the Western blot and cross absorption assays, a total of six cases were confirmed as R. africae infections and one

Discussion

Out of 26 clinically suspected patients, 8 (30.8%) were documented as having tick-borne SFG rickettsioses.

All patients were travellers returning from Africa. Six cases were caused by R. africae.

These observations are similar to other published findings, suggesting that a high proportion of imported tick-borne SFG rickettsioses diagnosed in travellers are acquired in southern Africa and that R. africae is the most commonly rickettsia acquired.4, 5, 6, 13, 14

Seven patients (88%) had an initial

Conflict of interest

None declared.

Acknowledgements

None.

References (18)

  • C.D. Paddock et al.

    Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever

    Clin Infect Dis

    (2008)
  • P. Parola et al.

    Tick borne rickettsioses around the world: emerging diseases challenging old concepts

    Clin Microbiol Rev

    (2005)
  • M.E. Wilson et al.

    Fever in returned travelers: results from the GeoSentinel Surveillance Network

    Clin Infect Dis

    (2007)
  • M. Jensenius et al.

    Multicenter GeoSentinel analysis of rickettsial diseases in international travelers, 1996–2008

    Emerg Infect Dis

    (2009)
  • M. Jensenius et al.

    Rickettsioses and the international traveler

    Clin Infect Dis

    (2004)
  • G. Caruso et al.

    Outbreak of African tick-bite fever in six Italian tourists returning from South Africa

    Eur J Clin Microbiol Infect Dis

    (2002)
  • S. Antinori et al.

    Prospective observational study of fever in hospitalized returning travelers and migrants from tropical areas, 1997–2001

    J Travel Med

    (2004)
  • L. Ciceroni et al.

    Current knowledge of rickettsial diseases in Italy

    Ann N Y Acad Sci

    (2006)
  • P.E. Fournier et al.

    Kinetics of antibody responses in Rickettsia africae and Rickettsia conorii infections

    Clin Diagn Lab Immunol

    (2002)
There are more references available in the full text version of this article.

Cited by (10)

  • Identification of rickettsial immunoreactive proteins using a proximity ligation assay Western blotting and the traditional immunoproteomic approach

    2018, Comparative Immunology, Microbiology and Infectious Diseases
    Citation Excerpt :

    Both R. africae and R. conorii were detected in ticks removed from humans in Turkey [18], also in ticks from Kenya [19] and should be considered as potential pathogens [20]. However, the cases with R. africae in Europe are all imported by travelers from endemic zones [21–23,7]. ATBF is usually a benign disease, but perhaps more severe for the elderly population [24].

  • Rickettsia diversity in southern Africa: A small mammal perspective

    2018, Ticks and Tick-borne Diseases
    Citation Excerpt :

    In addition, recent studies described R. massiliae in ticks from tortoises (Halajian et al., 2016) and R. felis in ticks from dogs (Kolo et al., 2016). R. africae has often been implicated in ATBF in travelers returning from South Africa and Swaziland (Jensenius et al., 1999; Raoult et al., 2001; Pretorius et al., 2004; Parola et al., 2005; Büchau et al., 2006; Roch et al., 2008; Tappe et al., 2009; Althaus et al., 2010; Wieten et al., 2011; Beltrame et al., 2012; Schleenvoigt et al., 2012; Socolovschi et al., 2012). Also, R. sibirica mongolitimonae was confirmed in a patient suffering from lymphangitis, headache, and fever in South Africa (Parola, 2006).

View all citing articles on Scopus
View full text